BR100 Decreased By (-0.15%)
BR30 Decreased By (-0.74%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.80 Decreased By ▼ -0.23 (-3.81%)
BML 58.03 Increased By ▲ 5.28 (10.01%)
BOP 33.85 Decreased By ▼ -0.40 (-1.17%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.77 Decreased By ▼ -0.57 (-4.62%)
FCCL 53.35 Decreased By ▼ -0.54 (-1%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.89 Decreased By ▼ -0.14 (-0.78%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.06 Increased By ▲ 0.06 (0.55%)
KEL 8.05 Decreased By ▼ -0.06 (-0.74%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.19 Decreased By ▼ -0.86 (-0.98%)
NBP 184.60 Decreased By ▼ -1.88 (-1.01%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.31 Increased By ▲ 0.37 (0.93%)
PIAHCLA 26.10 Decreased By ▼ -0.07 (-0.27%)
PIBTL 17.09 Decreased By ▼ -0.23 (-1.33%)
PPL 228.40 Decreased By ▼ -4.38 (-1.88%)
PRL 34.59 Decreased By ▼ -0.36 (-1.03%)
PTC 67.35 Decreased By ▼ -0.21 (-0.31%)
SEARL 91.00 Increased By ▲ 0.07 (0.08%)
SSGC 26.90 Decreased By ▼ -0.27 (-0.99%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.29 Increased By ▲ 0.53 (6.05%)
TREET 24.59 Increased By ▲ 0.05 (0.2%)
TRG 71.69 Decreased By ▼ -0.06 (-0.08%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
World

UK buys millions of Covid pills, cuts isolation period

Published December 22, 2021 Updated December 22, 2021 04:30pm
By

LONDON: The UK government announced Wednesday it is buying millions of doses of new Covid treatment pills as the Omicron variant takes hold, while cutting the isolation period for positive cases.

The government said it has signed deals to buy 4.25 million courses of two new antiviral drugs: Pfizer's ritonavir and US rival Merck/MSD's molnupiravir, which will be available early next year.

This comes on top of government announcements in October of the procurement of several hundreds of thousands of doses, and was hailed as a "mammoth deal" by Health Secretary Sajid Javid.

Molnupiravir, sold as Lagevrio, is being used in a national trial run by the University of Oxford that people can join if they have virus symptoms.

The government said it is also being made available to those who are at high risk of severe illness, such as people with cancer.

The UK was the first country in the world to approve the pill in November this year.

Pfizer's pill, marketed as Paxlovid, has yet to be authorised anywhere in the world.

Denmark first in EU to authorise Merck Covid pill

Pfizer said Tuesday that clinical trials showed it reduced hospital admissions and deaths among at-risk people by almost 90 percent, when taken a few days after symptoms began.

The government said it will be rolled out in the same way as molnupiravir "as quickly as possible" if the UK regulator approves it.

The UK has seen a surge in infections since Omicron became the dominant variant, with 90,629 cases reported Tuesday. The country is one of the hardest hit in Europe, with a death toll of 147,433.

Prime Minister Boris Johnson has resisted calls to impose stricter virus restrictions over Christmas in England, unlike the devolved governments in other UK nations.

From Wednesday, those who have caught the virus but feel well can come out of self-isolation after seven days instead of 10, potentially allowing more to join family celebrations.

This rule only applies to people who have taken two negative lateral flow tests, NHS England said.

At the same time, UK leaders were expected to announce fresh virus measures for the post-Christmas period.

Large New Year's Eve events have already been cancelled in London and Edinburgh.

Comments

Comments are closed for this article.